vanacof dm
Generic: dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
Labeler: gm pharmaceuticals, incDrug Facts
Product Profile
Brand Name
vanacof dm
Generic Name
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride
Labeler
gm pharmaceuticals, inc
Dosage Form
LIQUID
Routes
Active Ingredients
dextromethorphan hydrobromide 18 mg/15mL, guaifenesin 200 mg/15mL, phenylephrine hydrochloride 10 mg/15mL
Manufacturer
Identifiers & Regulatory
Product NDC
58809-555
Product ID
58809-555_42b78046-7cf6-3ab7-e063-6394a90a67a6
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2013-06-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
58809555
Hyphenated Format
58809-555
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
vanacof dm (source: ndc)
Generic Name
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 18 mg/15mL
- 200 mg/15mL
- 10 mg/15mL
Packaging
- 240 mL in 1 BOTTLE (58809-555-08)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "42b78046-7cf6-3ab7-e063-6394a90a67a6", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0358809555086"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1429362"], "spl_set_id": ["2ed699f2-d004-4fa9-8042-6c85a9ff69b6"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["GM Pharmaceuticals, INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE (58809-555-08)", "package_ndc": "58809-555-08", "marketing_start_date": "20130601"}], "brand_name": "VANACOF DM", "product_id": "58809-555_42b78046-7cf6-3ab7-e063-6394a90a67a6", "dosage_form": "LIQUID", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "58809-555", "generic_name": "DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE", "labeler_name": "GM Pharmaceuticals, INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "VANACOF DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "18 mg/15mL"}, {"name": "GUAIFENESIN", "strength": "200 mg/15mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/15mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20130601", "listing_expiration_date": "20261231"}